Carin A. Uyl‐de Groot

5.6k total citations
217 papers, 3.7k citations indexed

About

Carin A. Uyl‐de Groot is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carin A. Uyl‐de Groot has authored 217 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Oncology, 73 papers in Economics and Econometrics and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carin A. Uyl‐de Groot's work include Health Systems, Economic Evaluations, Quality of Life (63 papers), Economic and Financial Impacts of Cancer (35 papers) and Multiple Myeloma Research and Treatments (22 papers). Carin A. Uyl‐de Groot is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (63 papers), Economic and Financial Impacts of Cancer (35 papers) and Multiple Myeloma Research and Treatments (22 papers). Carin A. Uyl‐de Groot collaborates with scholars based in Netherlands, United Kingdom and United States. Carin A. Uyl‐de Groot's co-authors include Ken Redekop, Pieter Sonneveld, M Franken, Hedwig M. Blommestein, Martijn Groot, Michel van Agthoven, Peter C. Huijgens, Bob Löwenberg, Matthijs Versteegh and Elly Stolk and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Carin A. Uyl‐de Groot

202 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carin A. Uyl‐de Groot Netherlands 34 1.5k 905 889 512 436 217 3.7k
Paul G. Kluetz United States 34 1.8k 1.2× 1.3k 1.4× 671 0.8× 163 0.3× 579 1.3× 174 4.0k
Ajeet Gajra United States 29 2.2k 1.5× 1.9k 2.1× 573 0.6× 216 0.4× 469 1.1× 185 5.0k
Claudia Allemani United Kingdom 28 2.3k 1.6× 731 0.8× 298 0.3× 466 0.9× 515 1.2× 84 4.3k
Bishal Gyawali Canada 32 1.3k 0.9× 644 0.7× 1.6k 1.8× 225 0.4× 429 1.0× 221 4.3k
Johanneke E.A. Portielje Netherlands 33 1.7k 1.1× 571 0.6× 280 0.3× 389 0.8× 236 0.5× 144 3.4k
Roberta De Angelis Italy 34 3.3k 2.2× 1.2k 1.3× 469 0.5× 577 1.1× 855 2.0× 100 6.0k
Xianglin L. Du United States 46 4.0k 2.8× 1.6k 1.7× 842 0.9× 199 0.4× 520 1.2× 216 7.4k
Annalisa Trama Italy 30 2.3k 1.6× 1.9k 2.1× 294 0.3× 192 0.4× 605 1.4× 121 5.3k
Matthew C. Cheung Canada 28 1.2k 0.8× 282 0.3× 436 0.5× 289 0.6× 296 0.7× 248 2.8k
Raymond U. Osarogiagbon United States 31 845 0.6× 1.6k 1.8× 308 0.3× 391 0.8× 240 0.6× 169 3.1k

Countries citing papers authored by Carin A. Uyl‐de Groot

Since Specialization
Citations

This map shows the geographic impact of Carin A. Uyl‐de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carin A. Uyl‐de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carin A. Uyl‐de Groot more than expected).

Fields of papers citing papers by Carin A. Uyl‐de Groot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carin A. Uyl‐de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carin A. Uyl‐de Groot. The network helps show where Carin A. Uyl‐de Groot may publish in the future.

Co-authorship network of co-authors of Carin A. Uyl‐de Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Carin A. Uyl‐de Groot. A scholar is included among the top collaborators of Carin A. Uyl‐de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carin A. Uyl‐de Groot. Carin A. Uyl‐de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijngaarden, Jeroen D. H. van, Saskia de Groot, D. Andries Bosch, et al.. (2025). Moving from a registry to a learning health system: A case study of a Dutch prostate cancer registry. Learning Health Systems. 9(3). e10476–e10476.
2.
Calder, Philip C., Ella J. Baker, Joanna Góralska, et al.. (2025). Cost‐Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK. Journal of Human Nutrition and Dietetics. 38(3). e70071–e70071.
3.
Groot, Carin A. Uyl‐de, Corstiaan A. den Uil, Joseph S. Ross, et al.. (2025). Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries. Circulation Cardiovascular Quality and Outcomes. 18(4). e011636–e011636. 2 indexed citations
4.
Groot, Saskia de, Hedwig M. Blommestein, B Leeneman, et al.. (2025). Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma. Medical Decision Making. 45(3). 302–317.
5.
Kroesen, Michiel, et al.. (2025). Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study. Clinical and Translational Radiation Oncology. 51. 100913–100913.
6.
Mölken, Maureen Rutten‐van, Bernhard Wörmann, Daniel Widmer, et al.. (2025). Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy. Journal of Market Access & Health Policy. 13(1). 6–6.
9.
Sangers, Tobias E., Lytske Bakker, Loes M. Hollestein, et al.. (2023). An artificial intelligence based app for skin cancer detection evaluated in a population based setting. npj Digital Medicine. 6(1). 90–90. 43 indexed citations
11.
Hug, Martin J., et al.. (2023). Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices. Applied Health Economics and Health Policy. 21(6). 905–914. 3 indexed citations
12.
Westgeest, Hans M., Alfons J.M. van den Eertwegh, R. Jeroen A. van Moorselaar, et al.. (2021). Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands. Clinical Genitourinary Cancer. 20(1). 43–52. 2 indexed citations
13.
Leeneman, B, K. Schreuder, Carin A. Uyl‐de Groot, et al.. (2021). Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study. European Journal of Cancer. 154. 111–119. 27 indexed citations
14.
Leeneman, B, Carin A. Uyl‐de Groot, Maureen J.B. Aarts, et al.. (2020). Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs. Cancers. 12(4). 1003–1003. 12 indexed citations
15.
Franken, M, Tim A. Kanters, Jules L.L.M. Coenen, et al.. (2018). Potential cost savings owing to the route of administration of oncology drugs. Anti-Cancer Drugs. 29(8). 791–801. 30 indexed citations
16.
17.
Oosten, Liesbeth E.M., Martine E.D. Chamuleau, Frederick W. Thielen, et al.. (2017). Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. Annals of Hematology. 97(2). 255–266. 26 indexed citations
18.
Linden, Naomi van der, Carin A. Uyl‐de Groot, & Pierre W. Wijermans. (2010). ‘Patient’s en doctor’s delay’ bij multipel myeloom en de ziekte van Waldenström. 7(6). 218–223.
19.
Herder, Gerarda J.M., Henk Kramer, Otto S. Hoekstra, et al.. (2006). Traditional Versus Up-Front [ 18 F] Fluorodeoxyglucose–Positron Emission Tomography Staging of Non–Small-Cell Lung Cancer: A Dutch Cooperative Randomized Study. Journal of Clinical Oncology. 24(12). 1800–1806. 108 indexed citations
20.
Groot, Martijn, Rob Baltussen, Carin A. Uyl‐de Groot, Benjamin O. Anderson, & Gabriel N. Hortobágyi. (2006). Costs and Health Effects of Breast Cancer Interventions in Epidemiologically Different Regions of Africa, North America, and Asia. The Breast Journal. 12(s1). S81–S90. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026